OptiNose Financials

OptiNose Stock Summary

OptiNose competes with Elanco Animal, Superior Plus, NMI Holdings, Origin Agritech, and SIVERS SEMICONDUCTORS. OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania. OPTINOSE INC operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 204 people.

OptiNose Key Financial Ratios

There are many critical financial ratios that OptiNose's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that OptiNose reports annually and quarterly.

OptiNose Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining OptiNose's current stock value. Our valuation model uses many indicators to compare OptiNose value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OptiNose competition to find correlations between indicators driving OptiNose's intrinsic value. More Info.OptiNose is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the OptiNose's earnings, one of the primary drivers of an investment's value.

OptiNose Market Pulse

Along with financial statement analysis, the daily predictive indicators of OptiNose help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of OptiNose. We use our internally-developed statistical techniques to arrive at the intrinsic value of OptiNose based on widely used predictive technical indicators. In general, we focus on analyzing OptiNose Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build OptiNose's daily price indicators and compare them against related drivers.

When running OptiNose's price analysis, check to measure OptiNose's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OptiNose is operating at the current time. Most of OptiNose's value examination focuses on studying past and present price action to predict the probability of OptiNose's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OptiNose's price. Additionally, you may evaluate how the addition of OptiNose to your portfolios can decrease your overall portfolio volatility.